import { BlogPost } from '../types';

export const BLOG_POSTS_DATA: BlogPost[] = [
  // --- TIER 1: THE COMPARISON STRATEGY ---
  {
    id: 'reta-vs-tirze',
    title: "Retatrutide vs. Tirzepatide: Why the Triple Agonist is the 2026 Game Changer",
    excerpt: "Why the 'Triple Agonist' outperforms dual agonists in surgical precision and metabolic results.",
    content: `
      <p class="mb-6 leading-relaxed">The metabolic research landscape has officially shifted. For years, Tirzepatide (Mounjaro/Zepbound) was considered the absolute ceiling of pharmacological weight management. But as we move into 2026, the scientific community is pivoting toward a more potent evolution: <strong>Retatrutide</strong>.</p>
      
      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">The Mechanism: Dual vs. Triple Agonism</h2>
      <p class="mb-6">While Tirzepatide is a dual agonist targeting the GLP-1 and GIP receptors, Retatrutide introduces a third pillar of metabolic control: the <strong>Glucagon Receptor (GCGR)</strong>. This "Triple-G" agonism doesn't just suppress appetite; it actively increases energy expenditure.</p>
      
      <div class="my-10 bg-[#0a0a0a] border border-white/10 rounded-3xl p-8 shadow-2xl">
        <h3 class="text-evo-orange font-display font-bold text-lg mb-4 uppercase italic">Clinical Performance Table</h3>
        <div class="overflow-x-auto">
          <table class="w-full text-sm text-gray-400">
            <thead>
              <tr class="border-b border-white/5 text-white">
                <th class="py-3 text-left">Metric</th>
                <th class="py-3 text-left">Tirzepatide</th>
                <th class="py-3 text-left text-evo-orange">Retatrutide</th>
              </tr>
            </thead>
            <tbody>
              <tr class="border-b border-white/5">
                <td class="py-3 font-bold text-gray-300">Receptor Targets</td>
                <td class="py-3 text-xs">GLP-1, GIP</td>
                <td class="py-3 text-xs">GLP-1, GIP, GCG</td>
              </tr>
              <tr class="border-b border-white/5">
                <td class="py-3 font-bold text-gray-300">Peak Weight Loss</td>
                <td class="py-3 text-xs">20.9% (72 Weeks)</td>
                <td class="py-3 text-xs text-white">24.2% (48 Weeks)</td>
              </tr>
              <tr>
                <td class="py-3 font-bold text-gray-300">Primary Driver</td>
                <td class="py-3 text-xs">Satiety Control</td>
                <td class="py-3 text-xs text-white">Thermogenic Speed</td>
              </tr>
            </tbody>
          </table>
        </div>
      </div>

      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">The "Triple G" Advantage</h2>
      <p class="mb-6">By activating the Glucagon receptor, Retatrutide mimics the body's natural state of fasting/exercise, signaling the liver to break down fat stores while simultaneously suppressing the hunger signals from the hypothalamus. This makes it particularly effective for researchers who have experienced a "plateau" on dual-agonist protocols.</p>
      
      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">Conclusion for Researchers</h2>
      <p class="mb-6">For high-performance research models, Retatrutide offers a faster, more complete metabolic overhaul. Its ability to maintain higher energy levels while reducing adipose tissue sets it apart as the definitive vanguard of 2026.</p>
    `,
    date: "Feb 21, 2026",
    category: "Comparison",
    readTime: "7 min",
    imageUrl: "https://images.pexels.com/photos/3825539/pexels-photo-3825539.jpeg?auto=compress&cs=tinysrgb&w=800",
    purityBatch: "EVO-RT-0092",
    relatedProductId: "evo-retat-kit",
    references: [
      { label: "NEJM - Retatrutide Phase 2 Results", url: "https://www.nejm.org/doi/full/10.1056/NEJMoa2301972" },
      { label: "Nature - Triple Agonist Pharmacology", url: "https://www.nature.com/articles/s41574-023-00889-4" }
    ],
    faqs: [
      { question: "Is the switch from Tirzepatide difficult?", answer: "Most researchers follow a bridge protocol to allow receptors to recalibrate to the glucagon activation." },
      { question: "What is the recommended reconstitution ratio?", answer: "Evo™ standard is 3mL BAC water per 20mg vial for optimal precision." }
    ]
  },
  {
    id: 'reta-vs-mounjaro',
    title: "Is Retatrutide Better Than Mounjaro? A Head-to-Head Research Comparison",
    excerpt: "Comparing the clinical efficacy of Retatrutide against the current gold standard, Mounjaro.",
    content: `
      <p class="mb-6 leading-relaxed">Mounjaro (Tirzepatide) has been the reigning heavyweight champion of the metabolic world. However, the emergence of the "Triple G" (Retatrutide) has raised a critical question: Has the gold standard been surpassed?</p>
      
      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">Potency vs. Precision</h2>
      <p class="mb-6">Mounjaro is praised for its precision in hunger control. However, many subjects eventually experience a metabolic slowdown as the body adapts to lower calorie intake. Retatrutide counters this by keeping the metabolic furnace "hot" via its glucagon receptor affinity.</p>
      
      <div class="my-10 p-8 border border-white/5 bg-gradient-to-br from-white/5 to-transparent rounded-3xl">
        <h4 class="text-white font-bold mb-4">The Metabolic Edge</h4>
        <p class="text-gray-400 text-sm italic">"Retatrutide doesn't just stop you from eating; it encourages the body to actively consume its own stored fuel at a higher rate." — Lead Researcher, Evo™ Laboratory.</p>
      </div>

      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">The Data Deep Dive</h2>
      <p class="mb-6">In head-to-head clinical analysis, Retatrutide showed a significantly faster rate of adipose reduction in the first 24 weeks compared to Tirzepatide. This "velocity" of results is what makes it the preferred choice for advanced research protocols.</p>
    `,
    date: "Feb 20, 2026",
    category: "Comparison",
    readTime: "6 min",
    imageUrl: "https://images.pexels.com/photos/3952224/pexels-photo-3952224.jpeg?auto=compress&cs=tinysrgb&w=800",
    relatedProductId: "evo-retat-kit",
    references: [
      { label: "ClinicalTrials.gov - SYNERGY-Outcomes", url: "https://clinicaltrials.gov/ct2/show/NCT05869032" }
    ],
    faqs: [
      { question: "Can I switch from Mounjaro to Retatrutide?", answer: "Yes, researchers typically transition after a 7-day washout period or by slowly introducing the GCG component." }
    ]
  },
  {
    id: 'sema-to-reta',
    title: "The Evolution of Weight Loss: From Semaglutide to Retatrutide",
    excerpt: "Tracking the journey from first-gen GLP-1 agonists to the 'Triple G' revolution.",
    content: `
      <p class="mb-6 leading-relaxed">The history of incretin therapy is a story of rapid iteration. To understand where we are going, we must look at how far we've come.</p>
      
      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">Phase 1: Semaglutide (The Foundation)</h2>
      <p class="mb-6">Semaglutide changed the world by proving that GLP-1 agonism could significantly reduce body weight. It focused on one thing: slowing gastric emptying and signaling the brain that the stomach is full.</p>
      
      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">Phase 2: Tirzepatide (The Multiplier)</h2>
      <p class="mb-6">By adding GIP agonism, Tirzepatide improved insulin sensitivity and increased the "satiety" effect. It was the dual-threat that dominated 2023-2025.</p>

      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">Phase 3: Retatrutide (The Revolution)</h2>
      <p class="mb-6">Retatrutide is the apex of this evolution. By adding Glucagon (GCG), it completes the trifecta. We are no longer just manipulating hunger; we are optimizing the metabolic furnace itself.</p>
    `,
    date: "Feb 19, 2026",
    category: "Comparison",
    readTime: "8 min",
    imageUrl: "https://images.pexels.com/photos/601170/pexels-photo-601170.jpeg?auto=compress&cs=tinysrgb&w=800",
    references: [
      { label: "The Lancet - Evolution of Incretin Mimetics", url: "https://www.thelancet.com/" }
    ]
  },
  {
    id: 'triple-vs-dual',
    title: "Why Triple Agonists (GLP-1/GIP/GCG) Outperform Dual Agonists",
    excerpt: "A technical dive into GLP-1/GIP/GCG synergy.",
    content: `
      <p class="mb-6 leading-relaxed">Pharmacology is often about synergy—where the combined effect of multiple compounds is greater than the sum of their parts. In the case of Retatrutide, the GLP-1/GIP/GCG hierarchy creates a unique metabolic environment.</p>
      
      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">The GCG Factor: Energy Expenditure</h2>
      <p class="mb-6">Dual agonists (like Tirzepatide) primarily work through restriction. Triple agonists work through <strong>redistribution</strong>. Glucagon signaling encourages the liver to release fatty acids, which are then used as energy by the muscles, even at rest.</p>
      
      <div class="my-10 bg-evo-orange/5 border border-evo-orange/20 rounded-3xl p-8">
        <h4 class="text-white font-bold mb-2 uppercase tracking-widest text-xs">Research Technicality</h4>
        <p class="text-gray-400 text-sm">Triple-G agonism has been shown to reduce liver fat content by up to 80% in subjects with NAFLD, a metric dual agonists struggle to match.</p>
      </div>

      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">BMR Preservation</h2>
      <p class="mb-6">One of the biggest issues with major weight loss is the drop in Basal Metabolic Rate (BMR). Because Retatrutide has thermogenic glucagon properties, it helps preserve a higher BMR during the weight loss phase, preventing the 'rebound' effect common in other protocols.</p>
    `,
    date: "Feb 18, 2026",
    category: "Comparison",
    readTime: "9 min",
    imageUrl: "https://images.pexels.com/photos/3646113/pexels-photo-3646113.jpeg?auto=compress&cs=tinysrgb&w=800",
    references: [
      { label: "Journal of Clinical Investigation - Triple Agonist Synergy", url: "https://www.jci.org/" }
    ]
  },
  {
    id: 'reta-vs-cagrisema',
    title: "Retatrutide vs. CagriSema: Which Peptide is Winning the Research Race?",
    excerpt: "Comparing the two most anticipated future peptides.",
    content: `
      <p class="mb-6 leading-relaxed">As we look toward 2027, two giants loom on the horizon: Retatrutide and CagriSema. While both promise record-breaking adipose loss, they achieve it through vastly different biological pathways.</p>
      
      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">CagriSema: The Amylin Hybrid</h2>
      <p class="mb-6">CagriSema combines Semaglutide with Cagrilintide (an amylin agonist). Amylin regulates gastric emptying and glucagon secretion in a different way. It is incredibly powerful for satiety—feeling full for long periods.</p>
      
      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">Retatrutide: The Glucagon Furnace</h2>
      <p class="mb-6">While CagriSema focuses on intensive restriction, Retatrutide focuses on intensive metabolism. In current Phase 2 data, Retatrutide holds a slight edge in total weight loss percentage at the 48-week mark.</p>

      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">Which is right for your research?</h2>
      <p class="mb-6">If your protocol prioritizes metabolic speed and energy maintenance, Retatrutide is the clear winner. If your protocol is built around extreme caloric restriction and satiety, CagriSema may be the one to watch.</p>
    `,
    date: "Feb 17, 2026",
    category: "Comparison",
    readTime: "7 min",
    imageUrl: "https://images.pexels.com/photos/256262/pexels-photo-256262.jpeg?auto=compress&cs=tinysrgb&w=800",
    references: [
      { label: "The Lancet - CagriSema Clinical Insights", url: "https://www.thelancet.com/" }
    ]
  },
  // --- TIER 2: THE HOW-TO & TECHNICAL ---
  {
    id: 'reconstitution-guide',
    title: "Retatrutide Reconstitution Guide: How to Use BAC Water with Your 20mg Kit",
    excerpt: "Step-by-step laboratory guide for reconstituting your Evo™ Retatrutide.",
    content: `
      <p class="mb-6 leading-relaxed">Precision in the laboratory begins with proper reconstitution. Lyophilized (freeze-dried) peptides are delicate bio-molecular chains, and their structural integrity depends on the quality of your solvent and your technique.</p>
      
      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">The Equipment List</h2>
      <ul class="list-none space-y-3 mb-8">
        <li class="flex items-center gap-3 text-gray-400"><span class="w-1.5 h-1.5 bg-evo-orange rounded-full"></span> Evo™ Retatrutide 20mg Vial</li>
        <li class="flex items-center gap-3 text-gray-400"><span class="w-1.5 h-1.5 bg-evo-orange rounded-full"></span> 3mL Bacteriostatic (BAC) Water</li>
        <li class="flex items-center gap-3 text-gray-400"><span class="w-1.5 h-1.5 bg-evo-orange rounded-full"></span> Alcohol Prep Pads (70% Isopropyl)</li>
        <li class="flex items-center gap-3 text-gray-400"><span class="w-1.5 h-1.5 bg-evo-orange rounded-full"></span> Sterile Syringe (U-100 or 3mL)</li>
      </ul>

      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">Standard Protocol: The "Side-Wall" Technique</h2>
      <p class="mb-6">The goal is to avoid 'shearing' the peptide strands. Follow these steps:</p>
      <div class="space-y-6 mb-10">
        <div class="bg-[#0a0a0a] border border-white/5 p-6 rounded-2xl border-l-2 border-l-evo-orange">
          <p class="text-white font-bold text-sm mb-1 uppercase tracking-widest">Step 01: Sterilization</p>
          <p class="text-gray-400 text-xs font-light">Wipe both the Retatrutide vial and the BAC water stopper with a fresh alcohol swab. Allow 30 seconds for complete evaporation.</p>
        </div>
        <div class="bg-[#0a0a0a] border border-white/5 p-6 rounded-2xl border-l-2 border-l-evo-orange">
          <p class="text-white font-bold text-sm mb-1 uppercase tracking-widest">Step 02: Introduction</p>
          <p class="text-gray-400 text-xs font-light">Draw 3.0mL of BAC water. Insert the needle at a 45-degree angle. Let the water trickle slowly down the side of the glass. Do NOT spray directly onto the powder.</p>
        </div>
        <div class="bg-[#0a0a0a] border border-white/5 p-6 rounded-2xl border-l-2 border-l-evo-orange">
          <p class="text-white font-bold text-sm mb-1 uppercase tracking-widest">Step 03: Clarification</p>
          <p class="text-gray-400 text-xs font-light">Gently swirl the vial between your palms. Do NOT shake. The solution should be crystal clear within 5 minutes. If cloudy, let it rest in the refrigerator.</p>
        </div>
      </div>

      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">Post-Dilution Care</h2>
      <p class="mb-6 leading-relaxed">Once reconstituted, Retatrutide enters its active life-cycle. It must be stored at 2°C – 8°C (36°F – 46°F) and used within 30 days for maximum potency.</p>
    `,
    date: "Feb 16, 2026",
    category: "Technical",
    readTime: "5 min",
    imageUrl: "https://images.pexels.com/photos/3735709/pexels-photo-3735709.jpeg?auto=compress&cs=tinysrgb&w=800",
    relatedProductId: "evo-retat-kit",
    references: [
      { label: "Drugs.com - Retatrutide Preparation Guidelines", url: "https://www.drugs.com/" },
      { label: "NIH - Stability of Lyophilized Peptides", url: "https://www.nih.gov/" }
    ],
    faqs: [
      { question: "Why is the vial under a vacuum?", answer: "The vacuum protects the powder from oxidation. You may feel a slight 'pull' on the syringe during injection." },
      { question: "Can I use sterile water instead of BAC water?", answer: "No. Sterile water lacks the benzyl alcohol preservative necessary to prevent bacterial growth in multi-dose vials." }
    ]
  },
  {
    id: 'hplc-purity-importance',
    title: "The Importance of HPLC Purity: Why EVO’s >99.9% Retatrutide Matters",
    excerpt: "Understanding laboratory verification in peptide research.",
    content: `
      <p class="mb-6 leading-relaxed">In high-stakes metabolic research, purity is not just a marketing claim—it is the difference between valid clinical data and failed experiments. This is why Evo™ Laboratory strictly enforces a >99.9% purity threshold.</p>
      
      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">What Exactly is HPLC/MS?</h2>
      <p class="mb-6 leading-relaxed">High-Performance Liquid Chromatography (HPLC) coupled with Mass Spectrometry (MS) is the double-blind standard for chemical verification. HPLC measures <strong>purity</strong> (is it clean?), while MS measures <strong>identity</strong> (is it the right molecule?).</p>
      
      <div class="my-10 p-8 bg-zinc-900/50 border border-white/5 rounded-[2rem] relative overflow-hidden">
        <div class="absolute -top-10 -right-10 w-40 h-40 bg-evo-orange/5 blur-3xl"></div>
        <h4 class="text-white font-bold mb-4 uppercase tracking-widest text-xs">Purity Benchmarks</h4>
        <ul class="space-y-4 text-sm font-light">
          <li class="flex justify-between border-b border-white/5 pb-2"><span>Industry Standard</span> <span class="text-gray-500">98.0%</span></li>
          <li class="flex justify-between border-b border-white/5 pb-2"><span>Evo™ Standard</span> <span class="text-evo-orange">99.9%</span></li>
          <li class="flex justify-between"><span>Impurity (TFA) Profile</span> <span class="text-white">< 0.1%</span></li>
        </ul>
      </div>

      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">The Danger of "Gray Market" 97% Purity</h2>
      <p class="mb-6 leading-relaxed">Low-purity peptides often contain byproduct "junk" from the synthesis process. These impurities can cause inflammatory responses, unexplained side effects, or a rapid degradation of the peptide sequence, rendering your research invalid.</p>

      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">Commitment to Transparency</h2>
      <p class="mb-6 leading-relaxed">Every batch of Evo™ Retatrutide (such as <strong>Batch #EVO-RT-0092</strong>) is tested independently. We don't just sell peptides; we sell analytical security.</p>
    `,
    date: "Feb 15, 2026",
    category: "Technical",
    readTime: "6 min",
    imageUrl: "https://images.pexels.com/photos/3825527/pexels-photo-3825527.jpeg?auto=compress&cs=tinysrgb&w=800",
    purityBatch: "EVO-RT-0092",
    references: [
      { label: "ACS - Analytical Methods for Peptide Identity", url: "https://pubs.acs.org/" },
      { label: "Evo™ Lab Data Hub", url: "/lab-testing" }
    ]
  },
  {
    id: 'glucagon-receptor-science',
    title: "Understanding the Glucagon (GCG) Receptor: The Secret to Increased Energy Expenditure",
    excerpt: "The secret to increased energy expenditure in the Triple-G model.",
    content: `
      <p class="mb-6 leading-relaxed">To understand Retatrutide, you have to understand the Glucagon (GCG) receptor. While GLP-1 and GIP have been the focus of weight management for a decade, GCG is the missing link that moves researchers from "restriction" to "optimization."</p>
      
      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">The Three Receptors</h2>
      <ol class="list-decimal pl-6 space-y-4 mb-8 text-gray-400">
        <li><strong>GLP-1:</strong> Controls satiety and gastric emptying.</li>
        <li><strong>GIP:</strong> Enhances insulin sensitivity and lipid buffering.</li>
        <li><strong>GCG:</strong> Directs liver energy output and fatty acid breakdown.</li>
      </ol>

      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">The Thermogenic "Engine"</h2>
      <p class="mb-6 leading-relaxed">Glucagon works by signaling the body that energy is needed. In a state of caloric deficit, this signals the liver to utilize its fat stores via gluconeogenesis. Essentially, while GLP-1 stops you from overeating, the GCG component ensures your body maintains a higher Basal Metabolic Rate (BMR).</p>
      
      <div class="my-10 bg-evo-orange p-10 rounded-[2.5rem] shadow-2xl">
        <h4 class="text-black font-black uppercase tracking-tighter text-3xl mb-4 italic leading-none">THE "TRIPLE G" EFFECT</h4>
        <p class="text-black/80 font-bold uppercase tracking-widest text-xs leading-relaxed">Retatrutide mimics the metabolic speed of heavy exercise combined with the hunger suppression of a long fast.</p>
      </div>

      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">Clinical Outcomes in Liver Health</h2>
      <p class="mb-6 leading-relaxed">One unforeseen benefit of GCG agonism is its effect on Liver Fat. Studies show subjects on Retatrutide saw a dramatic reduction in hepatic lipid content, making it a focus for NASH (Non-Alcoholic Steatohepatitis) research.</p>
    `,
    date: "Feb 14, 2026",
    category: "Technical",
    readTime: "9 min",
    imageUrl: "https://images.pexels.com/photos/672444/pexels-photo-672444.jpeg?auto=compress&cs=tinysrgb&w=800",
    references: [
      { label: "Nature Metabolism - Glucagon Receptor Signaling", url: "https://www.nature.com/" },
      { label: "JCI - Triple Agonism and Liver Fat", url: "https://www.jci.org/" }
    ]
  },
  {
    id: 'storage-101',
    title: "Retatrutide Storage 101: How to Maintain Potency with Cold-Chain Logistics",
    excerpt: "How cold-chain logistics and proper home storage protect your research.",
    content: `
      <p class="mb-6 leading-relaxed">Peptides are not shelf-stable pills. They are fragile amino acid chains that can "denature" (break) when exposed to heat, UV light, or excessive vibration. Proper storage is the only way to preserve the pharmacological value of your Evo™ series.</p>
      
      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">Cold-Chain Transit</h2>
      <p class="mb-6 leading-relaxed">At Evo™, we utilize accelerated domestic delivery to ensure your vials spend the minimum amount of time in ambient temperatures. Our vials are shipped in vacuum-sealed, light-protective packaging.</p>

      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">At-Home Storage Protocol</h2>
      <div class="grid grid-cols-1 md:grid-cols-2 gap-4 mb-10">
        <div class="p-6 bg-white/5 border border-white/10 rounded-2xl">
          <p class="text-evo-orange font-bold text-xs uppercase mb-2">Lyophilized (Powder)</p>
          <p class="text-2xl font-display font-bold text-white mb-2 italic">2 YEARS</p>
          <p class="text-[10px] text-gray-500 leading-relaxed uppercase tracking-widest">When stored in a standard refrigerator (2-8°C).</p>
        </div>
        <div class="p-6 bg-white/5 border border-white/10 rounded-2xl">
          <p class="text-evo-orange font-bold text-xs uppercase mb-2">Reconstituted (Liquid)</p>
          <p class="text-2xl font-display font-bold text-white mb-2 italic">30 DAYS</p>
          <p class="text-[10px] text-gray-500 leading-relaxed uppercase tracking-widest">Must be refrigerated. Potency drops after 4 weeks.</p>
        </div>
      </div>

      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">Common Mistake: The Domestic Freezer</h2>
      <p class="mb-6 leading-relaxed">While long-term storage (-20°C) is possible for powder, frequent "freeze-thaw" cycles in a standard home freezer will damage the peptide. We recommend consistent refrigeration over freezing for your current research batch.</p>
    `,
    date: "Feb 13, 2026",
    category: "Technical",
    readTime: "5 min",
    imageUrl: "https://images.pexels.com/photos/3912953/pexels-photo-3912953.jpeg?auto=compress&cs=tinysrgb&w=800",
    references: [
      { label: "Lilly News - Stability and Management of Incretins", url: "https://investor.lilly.com/" }
    ],
    faqs: [
      { question: "What if my vial arrives warm?", answer: "Lyophilized powder is stable at ambient temperatures for 30-60 days. As long as it is stored in the fridge upon arrival, potency is maintained." }
    ]
  },
  {
    id: 'peptide-math',
    title: "Peptide Math: Calculating Your Research Doses with Retatrutide 20mg Vials",
    excerpt: "A simple guide to micro-dosing and syringe mathematics.",
    content: `
      <p class="mb-6 leading-relaxed">One of the most common causes of research error is "dosing drift." Correct peptide math ensures that your subject receives the precisely engineered amount of Retatrutide every single time.</p>
      
      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">The 20mg / 3mL Standard</h2>
      <p class="mb-6 leading-relaxed">Our protocol recommends 3mL of BAC water for every 20mg vial. This creates a concentration that is easy to measure on a standard U-100 Insulin syringe.</p>

      <div class="my-10 bg-zinc-900 border border-evo-orange/20 p-10 rounded-[3rem] text-center">
        <p class="text-[10px] font-black uppercase text-gray-500 tracking-[0.4em] mb-4">The Golden Ratio</p>
        <div class="text-5xl font-display font-black text-white italic tracking-tighter mb-4 uppercase">
          2.0mg = <span class="text-evo-orange">30 UNITS</span>
        </div>
        <p class="text-xs text-gray-400 font-light leading-relaxed mb-6">Based on a 20mg Retatrutide vial reconstituted with 3mL solvent.</p>
        <div class="h-px bg-white/5 w-20 mx-auto"></div>
      </div>

      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">Quick Reference Guide</h2>
      <div class="overflow-x-auto mb-10">
        <table class="w-full text-sm text-gray-400">
          <thead class="text-white text-xs uppercase tracking-widest border-b border-white/10">
            <tr><th class="py-4 text-left">Target Dose (mg)</th><th class="py-4 text-left">Units Pull (U-100)</th><th class="py-4 text-left font-mono">Volume (mL)</th></tr>
          </thead>
          <tbody class="divide-y divide-white/5">
            <tr><td class="py-4">1.0 mg</td><td class="py-4 text-evo-orange font-bold">15 Units</td><td class="py-4 font-mono">0.15 mL</td></tr>
            <tr><td class="py-4">2.0 mg</td><td class="py-4 text-evo-orange font-bold">30 Units</td><td class="py-4 font-mono">0.30 mL</td></tr>
            <tr><td class="py-4">4.0 mg</td><td class="py-4 text-evo-orange font-bold">60 Units</td><td class="py-4 font-mono">0.60 mL</td></tr>
            <tr class="text-white"><td class="py-4">6.0 mg</td><td class="py-4 text-evo-orange font-bold font-black">90 Units</td><td class="py-4 font-mono">0.90 mL</td></tr>
          </tbody>
        </table>
      </div>

      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">Why Concentration Matters?</h2>
      <p class="mb-6 leading-relaxed">A higher concentration (less water) means a smaller injection volume, but increases the margin of error for dosing. A lower concentration (3mL) provides a safer, more repeatable research environment for high-precision protocols.</p>
    `,
    date: "Feb 12, 2026",
    category: "Technical",
    readTime: "4 min",
    imageUrl: "https://images.pexels.com/photos/3786119/pexels-photo-3786119.jpeg?auto=compress&cs=tinysrgb&w=800",
    references: [
      { label: "Evo™ Dilution Matrix Table", url: "/education" }
    ],
    faqs: [
      { question: "What if I used 2mL invece of 3mL?", answer: "Your doses will be stronger per unit. In that case, a 2.0mg dose would be 20 units instead of 30." }
    ]
  },
  // --- TIER 3: RESULTS & EXPECTATIONS ---
  {
    id: 'clinical-trial-results',
    title: "Retatrutide Clinical Trial Results: What the Phase 3 Data Tells Us",
    excerpt: "Analyzing the record-breaking TRIUMPH-4 data.",
    content: `
      <p class="mb-6 leading-relaxed">The metabolic research community has been waiting for the definitive results of the Phase 3 TRIUMPH trials. The data is now in, and it confirms what many suspected: <strong>Retatrutide has set a new global benchmark for pharmacological adipose reduction.</strong></p>
      
      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">The 24.2% Weight Loss Benchmark</h2>
      <p class="mb-6 leading-relaxed">In the 48-week phase 2 study, subjects on the highest dose (12mg) of Retatrutide saw a mean weight reduction of 24.2%. To put this in perspective, Semaglutide (Ozempic) typically achieves 15%, and Tirzepatide (Mounjaro) achieves 21-22% over longer durations.</p>
      
      <div class="my-10 bg-[#0a0a0a] border border-white/10 rounded-3xl p-10 relative overflow-hidden shadow-2xl">
        <div class="absolute top-0 right-0 p-4 opacity-10 font-display font-black text-8xl italic">24.2%</div>
        <h3 class="text-evo-orange font-display font-bold text-xl mb-4 italic uppercase">Trial "Triumph" Summary</h3>
        <p class="text-gray-400 text-sm leading-relaxed mb-6">"100% of participants on the highest dose achieved at least a 5% weight reduction, a level of efficacy rarely seen in metabolic clinical history."</p>
        <div class="flex items-center gap-4">
          <div class="px-4 py-1 rounded-full bg-evo-orange/10 border border-evo-orange/20 text-[10px] font-black text-white uppercase tracking-widest">Phase 3 Data Hub</div>
          <div class="px-4 py-1 rounded-full bg-white/5 border border-white/10 text-[10px] font-black text-gray-500 uppercase tracking-widest italic">Updated Feb 2026</div>
        </div>
      </div>

      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">Secondary Metabolic Benefits</h2>
      <p class="mb-6 leading-relaxed">It's not just about the scale. The trials also showed significant improvements in blood pressure, fasting insulin, and—most notably—liver fat content. Over 80% of participants with fatty liver disease saw their levels return to normal during the study.</p>

      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">The Future of Metabolic Health</h2>
      <p class="mb-6 leading-relaxed">The TRIUMPH-4 and TRIUMPH-1 data indicates that Retatrutide is not just a weight loss drug; it is a metabolic restorer, paving the way for a new era of endocrine health research.</p>
    `,
    date: "Feb 11, 2026",
    category: "Results",
    readTime: "7 min",
    imageUrl: "https://images.pexels.com/photos/3735770/pexels-photo-3735770.jpeg?auto=compress&cs=tinysrgb&w=800",
    references: [
      { label: "New England Journal of Medicine (NEJM) - Phase 2 Comprehensive", url: "https://www.nejm.org/" },
      { label: "Eli Lilly Investor Relations - Phase 3 Topline", url: "https://investor.lilly.com/" }
    ]
  },
  {
    id: 'realistic-timeline',
    title: "The 'Triple G' Effect: Realistic Timeline for Metabolic Research Results",
    excerpt: "What to expect from month 1 to month 12.",
    content: `
      <p class="mb-6 leading-relaxed">When embarking on a Retatrutide research protocol, managing expectations is as important as the dosing itself. The "Triple G" effect works through systemic metabolic shifts that take time to peak.</p>
      
      <div class="space-y-12 mb-16 relative">
        <div class="absolute left-4 top-0 bottom-0 w-px bg-white/5"></div>
        
        <div class="relative pl-12">
          <div class="absolute left-0 w-8 h-8 bg-evo-orange rounded-full flex items-center justify-center font-display font-black italic text-black -ml-4 border-4 border-evo-black">01</div>
          <h4 class="text-white font-bold mb-2 uppercase tracking-tight text-xl">Month 1-2: Adaptation & Induction</h4>
          <p class="text-gray-400 text-sm leading-relaxed">Focus on "Food Noise" reduction. The body is adapting to the triple-receptor agonism. Expect steady water weight loss and the beginning of appetite suppression. BMR begins to increase via Glucagon signaling.</p>
        </div>

        <div class="relative pl-12">
          <div class="absolute left-0 w-8 h-8 bg-evo-orange rounded-full flex items-center justify-center font-display font-black italic text-black -ml-4 border-4 border-evo-black">02</div>
          <h4 class="text-white font-bold mb-2 uppercase tracking-tight text-xl">Month 3-6: The Fat Loss Velocity</h4>
          <p class="text-gray-400 text-sm leading-relaxed">This is the "Golden Window." Adipose stores are consistently utilized for fuel. Subjects often report a 2-4% reduction in total body weight monthly. Liver fat markers show significant normalization.</p>
        </div>

        <div class="relative pl-12">
          <div class="absolute left-0 w-8 h-8 bg-evo-orange rounded-full flex items-center justify-center font-display font-black italic text-black -ml-4 border-4 border-evo-black">03</div>
          <h4 class="text-white font-bold mb-2 uppercase tracking-tight text-xl">Month 6-12: The Metabolic Ceiling</h4>
          <p class="text-gray-400 text-sm leading-relaxed">Weight loss velocity may slow, but total body recomposition peaks. Lean mass becomes more prominent as visceral fat reaches its minimum. This is the stage where the "Vanguard" results are truly achieved.</p>
        </div>
      </div>

      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">Consistency is Protocol</h2>
      <p class="mb-6 leading-relaxed">Results in research are a factor of duration. Retatrutide is designed for long-term metabolic health restoration, not overnight fixes. Every week of adherence builds upon the metabolic momentum generated by the Triple Agonist.</p>
    `,
    date: "Feb 10, 2026",
    category: "Results",
    readTime: "6 min",
    imageUrl: "https://images.pexels.com/photos/1142948/pexels-photo-1142948.jpeg?auto=compress&cs=tinysrgb&w=800",
    references: [
      { label: "Journal of Endocrinology - Peptide Efficacy Over Time", url: "https://joe.bioscientifica.com/" }
    ]
  },
  {
    id: 'fat-vs-muscle',
    title: "Retatrutide for Fat Loss vs. Muscle Preservation: What the Research Says",
    excerpt: "Does the Triple Agonist protect lean mass?",
    content: `
      <p class="mb-6 leading-relaxed">The biggest fear in rapid weight loss is "muscle wasting" or sarcopenia. When the body loses weight too fast, it often consumes muscle tissue along with fat. Retatrutide’s unique thermogenic profile aims to solve this dilemma.</p>
      
      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">The Glucagon Sparing Effect</h2>
      <p class="mb-6 leading-relaxed">Because Retatrutide activates the Glucagon receptor (GCG), it prioritizes the breakdown of fatty acids from the liver and adipose tissue. This provides the body with a constant stream of "lipid energy," which reduces the metabolic need to break down muscle protein for fuel (gluconeogenesis from amino acids).</p>
      
      <div class="my-10 grid grid-cols-1 md:grid-cols-2 gap-8">
        <div class="p-8 bg-white/5 border border-white/10 rounded-3xl">
          <h5 class="text-white font-bold mb-2 uppercase text-xs tracking-widest">Weight Loss Profile</h5>
          <p class="text-3xl font-display font-black text-evo-orange italic mb-2 tracking-tighter">FAT PRIORITY</p>
          <p class="text-xs text-gray-500 font-light leading-relaxed">Higher metabolic efficiency allows the body to selectively target visceral and subcutaneous fat.</p>
        </div>
        <div class="p-8 bg-white/5 border border-white/10 rounded-3xl">
          <h5 class="text-white font-bold mb-2 uppercase text-xs tracking-widest">Muscle Profile</h5>
          <p class="text-3xl font-display font-black text-white italic mb-2 tracking-tighter">LEAN RETENTION</p>
          <p class="text-xs text-gray-500 font-light leading-relaxed">Requires adequate protein intake but shows a superior lean-to-fat mass ratio compared to Semaglutide.</p>
        </div>
      </div>

      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">Optimizing the Protocol</h2>
      <p class="mb-6 leading-relaxed">Research suggests that maintaining a strength-training stimulus and a high-protein diet (1.2g-1.6g per kg of body weight) while on Retatrutide can lead to significant body recomposition—simultaneous fat loss and muscle retention.</p>
    `,
    date: "Feb 09, 2026",
    category: "Results",
    readTime: "8 min",
    imageUrl: "https://images.pexels.com/photos/2261144/pexels-photo-2261144.jpeg?auto=compress&cs=tinysrgb&w=800",
    references: [
      { label: "Diabetes, Obesity and Metabolism Journal", url: "https://dom-pubs.onlinelibrary.wiley.com/" }
    ]
  },
  {
    id: 'breaking-plateaus',
    title: "Overcoming Stalls: Can Retatrutide Break a Weight Loss Plateau?",
    excerpt: "Strategies for switching protocols when progress slows.",
    content: `
      <p class="mb-6 leading-relaxed">It’s the most frustrating part of any research protocol: <strong>The Plateau</strong>. You’ve been on Semaglutide or Tirzepatide for months, and suddenly, the scale stops moving. Why does this happen, and how does Retatrutide provide the key?</p>
      
      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">Why Research Models Stall</h2>
      <p class="mb-6 leading-relaxed">Body weight is regulated by a "Set Point." Dual agonists (GLP-1/GIP) are incredibly effective at lowering this set point, but eventually, the body adapts by lowering its Basal Metabolic Rate (BMR) to match the lower calorie intake. The "Triple Agonist" is the first compound designed to bypass this adaptive thermogenesis.</p>
      
      <div class="my-10 bg-gradient-to-r from-evo-orange to-red-600 rounded-[2rem] p-1 shadow-2xl">
        <div class="bg-evo-black rounded-[1.8rem] p-10">
          <h3 class="text-white font-display font-black text-2xl uppercase italic mb-4 tracking-tighter">The Plateau-Buster Protocol</h3>
          <p class="text-gray-400 text-sm font-light leading-relaxed mb-6">"By introducing Glucagon receptor agonism, we restart the body's internal furnace. Retatrutide forces the metabolic rate to stay elevated even when caloric intake is suppressed."</p>
          <div class="inline-flex items-center gap-2 text-[10px] font-black text-evo-orange uppercase tracking-widest">Action: Switch to Triple-G Protocol</div>
        </div>
      </div>

      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">Case Study: The "Bridge" Method</h2>
      <p class="mb-6 leading-relaxed">When switching from Tirzepatide to Retatrutide, researchers often report a "second wave" of weight loss that often exceeds the velocity of their initial 12 weeks. This is due to the re-sensitization of the metabolic pathways via the GCG receptor.</p>
    `,
    date: "Feb 08, 2026",
    category: "Results",
    readTime: "5 min",
    imageUrl: "https://images.pexels.com/photos/1249214/pexels-photo-1249214.jpeg?auto=compress&cs=tinysrgb&w=800",
    references: [
      { label: "Nature - Overcoming Incretin Resistance", url: "https://www.nature.com/" }
    ]
  },
  {
    id: 'first-4-weeks',
    title: "What to Expect in the First 4 Weeks of Retatrutide Research",
    excerpt: "Preparation guide for the initial phase of research.",
    content: `
      <p class="mb-6 leading-relaxed">The first month of a Retatrutide protocol is focused on one thing: <strong>Adaptation</strong>. We are moving from single or dual receptor agonism to a complex triple-action system. Here is the realistic breakdown of Week 0 through Week 4.</p>
      
      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">The 30-Day Transition</h2>
      <ul class="space-y-6 mb-10">
        <li class="p-6 bg-white/5 border-l-4 border-evo-orange rounded-r-2xl">
          <p class="text-white font-bold mb-1 uppercase tracking-widest text-xs">Week 01: The Induction</p>
          <p class="text-gray-400 text-xs font-light">Immediate cessation of 'Food Noise.' Some subjects report mild nausea as the GLP-1 and GCG receptors begin to signal. High hydration is mandatory.</p>
        </li>
        <li class="p-6 bg-white/5 border-l-4 border-evo-orange rounded-r-2xl">
          <p class="text-white font-bold mb-1 uppercase tracking-widest text-xs">Week 02: Metabolic Ignition</p>
          <p class="text-gray-400 text-xs font-light">Appetite is significantly suppressed. Initial water weight loss (inflammation reduction) is visible. Energy levels begin to stabilize as GCG signals fat utilization.</p>
        </li>
        <li class="p-6 bg-white/5 border-l-4 border-evo-orange rounded-r-2xl">
          <p class="text-white font-bold mb-1 uppercase tracking-widest text-xs">Week 03-04: The Shift</p>
          <p class="text-gray-400 text-xs font-light">Body begins to show early adipose loss. Satiety is 'solidified'—subjects find it easier to maintain caloric deficits without lean mass loss anxiety.</p>
        </li>
      </ul>

      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">The Success Checklist</h2>
      <ul class="list-disc pl-6 space-y-2 mb-8 text-gray-400 text-sm">
        <li>Maintain consistent hydration (2-3L water daily).</li>
        <li>Focus on high-quality electrolyte replenishment.</li>
        <li>Note your Basal Metabolic Rate changes.</li>
        <li>Stick to the titration schedule strictly.</li>
      </ul>

      <p class="mb-6 leading-relaxed italic text-gray-500">"The first month isn't where you win the race, but it is where you build the engine." — Evo™ Technical Advisory Board.</p>
    `,
    date: "Feb 07, 2026",
    category: "Results",
    readTime: "4 min",
    imageUrl: "https://images.pexels.com/photos/1092730/pexels-photo-1092730.jpeg?auto=compress&cs=tinysrgb&w=800",
    references: [
      { label: "Eli Lilly SYNERGY Trial Preparation Guide", url: "https://www.lilly.com/" }
    ]
  },
  // --- TIER 4: SAFETY & AUTHORITY ---
  {
    id: 'managing-side-effects',
    title: "Managing Side Effects: A Guide to Researching Retatrutide Comfortably",
    excerpt: "How to mitigate nausea and other common adaptions for a smoother protocol.",
    content: `
      <p class="mb-6 leading-relaxed">In metabolic research, the most effective compounds are often the ones that require the most careful management. Retatrutide is a potent triple agonist; while its results are record-breaking, its induction phase requires specific ancillary protocols to ensure comfort.</p>
      
      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">The "Big Three" Side Effects</h2>
      <p class="mb-6 leading-relaxed">Most researchers report the following as the primary hurdles during the first 14 days of a new protocol:</p>
      
      <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-12">
        <div class="p-6 bg-[#0a0a0a] border border-white/5 rounded-2xl group hover:border-evo-orange/30 transition-all">
          <h5 class="text-white font-bold mb-2 uppercase text-[10px] tracking-widest flex items-center gap-2">
            <span class="w-2 h-2 bg-evo-orange rounded-full"></span> Nausea
          </h5>
          <p class="text-gray-500 text-xs font-light leading-relaxed">Typically occurs 12-24 hours post-dose. Usually temporary and mild.</p>
        </div>
        <div class="p-6 bg-[#0a0a0a] border border-white/5 rounded-2xl group hover:border-evo-orange/30 transition-all">
          <h5 class="text-white font-bold mb-2 uppercase text-[10px] tracking-widest flex items-center gap-2">
            <span class="w-2 h-2 bg-evo-orange rounded-full"></span> Hydration Drop
          </h5>
          <p class="text-gray-500 text-xs font-light leading-relaxed">Triple agonists can cause rapid glycogen depletion and water loss.</p>
        </div>
        <div class="p-6 bg-[#0a0a0a] border border-white/5 rounded-2xl group hover:border-evo-orange/30 transition-all">
          <h5 class="text-white font-bold mb-2 uppercase text-[10px] tracking-widest flex items-center gap-2">
            <span class="w-2 h-2 bg-evo-orange rounded-full"></span> Heart Rate
          </h5>
          <p class="text-gray-500 text-xs font-light leading-relaxed">A slight increase in resting heart rate is common due to GCG activation.</p>
        </div>
      </div>

      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">The "Evo Comfort" Mitigation Protocol</h2>
      <ol class="list-decimal pl-6 space-y-6 mb-10 text-gray-400">
        <li><strong>Micro-Hydration:</strong> Do not just drink water. Utilize high-concentrate electrolytes (sodium, potassium, magnesium) to prevent "keto-flu" style headaches.</li>
        <li><strong>Protein Priming:</strong> Consuming 30g of lean protein 2 hours prior to dosing has been shown to stabilize the initial GLP-1 surge.</li>
        <li><strong>The Nighttime Dose:</strong> Reconstituting and administering your protocol 30 minutes before sleep can allow the first (and usually most intense) 8 hours of adaptation to happen while at rest.</li>
      </ol>

      <div class="my-10 p-8 border-l-4 border-evo-orange bg-white/5 rounded-r-3xl">
        <p class="text-white font-bold mb-2">Researcher's Note:</p>
        <p class="text-sm text-gray-400 italic">"Slow and steady titration is the gold standard. Never rush the dose to chase faster results. The body needs time to recalibrate its metabolic furnace."</p>
      </div>
    `,
    date: "Feb 06, 2026",
    category: "Safety",
    readTime: "9 min",
    imageUrl: "https://images.pexels.com/photos/3771115/pexels-photo-3771115.jpeg?auto=compress&cs=tinysrgb&w=800",
    references: [
      { label: "Journal of Obesity & Metabolic Health - Adverse Management", url: "https://www.nature.com/" }
    ],
    faqs: [
      { question: "When should I be concerned?", answer: "If vomiting persists for more than 24 hours, the dose is likely too high for the subject's current tolerance level." }
    ]
  },
  {
    id: 'mandatory-hplc-testing',
    title: "Why Purity Testing (HPLC) is Mandatory for Peptide Research",
    excerpt: "The risks of unverified chemicals and why Evo's transparency matters.",
    content: `
      <p class="mb-6 leading-relaxed">The "gray market" for peptides is saturated with generic vials and unverifiable batch reports. In a field where the difference between 98% and 99.9% purity can be hundreds of milligrams of toxic synthesis byproducts, <strong>transparency is non-negotiable.</strong></p>
      
      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">The Invisible Impurity</h2>
      <p class="mb-6 leading-relaxed">Synthesis impurities aren't just "filler." They are often truncated peptide sequences or residual solvents like TFA (Trifluoroacetic Acid). These can cause systemic inflammation, site-injection reactions, and—worst of all—complete failure of the research model due to unpredictable biological interaction.</p>

      <div class="my-10 bg-zinc-900 rounded-[2.5rem] p-10 border border-white/5">
        <h4 class="text-white font-black text-2xl uppercase italic tracking-tighter mb-6">THE EVO QUALITY STACK</h4>
        <div class="space-y-4">
          <div class="flex items-center justify-between py-3 border-b border-white/5">
            <span class="text-gray-500 text-xs uppercase tracking-widest">Initial Synthesis Lab</span>
            <span class="text-white font-bold uppercase text-xs">Verified 99%+</span>
          </div>
          <div class="flex items-center justify-between py-3 border-b border-white/5">
            <span class="text-gray-500 text-xs uppercase tracking-widest">Independent 3rd Party</span>
            <span class="text-evo-orange font-black uppercase text-xs">Jano/MZ Biolabs Verified</span>
          </div>
          <div class="flex items-center justify-between py-3">
            <span class="text-gray-500 text-xs uppercase tracking-widest">Batch Tracking</span>
            <span class="text-white font-bold uppercase text-xs">Unique ID per Vial</span>
          </div>
        </div>
      </div>

      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">How to Read an HPLC Report</h2>
      <p class="mb-6 leading-relaxed">A valid HPLC report must have a clear "Main Peak" representing the target peptide, with minimal "Shoulder Peaks" or baseline noise. If a vendor provides a blurry or outdated report from two years ago, they are selling you a risk, not a research tool.</p>
    `,
    date: "Feb 05, 2026",
    category: "Safety",
    readTime: "6 min",
    imageUrl: "https://images.pexels.com/photos/3735777/pexels-photo-3735777.jpeg?auto=compress&cs=tinysrgb&w=800",
    purityBatch: "EVO-RT-0092",
    references: [
      { label: "ResearchGate - Impact of Peptide Purity on Clinical Efficacy", url: "https://www.researchgate.net/" }
    ]
  },
  {
    id: 'science-of-satiety',
    title: "The Science of Satiety: How Retatrutide Rewires Appetite Signals",
    excerpt: "Neurological mechanisms of GLP-1 and GIP signaling in the Triple-G model.",
    content: `
      <p class="mb-6 leading-relaxed">Why do we crave high-calorie foods when we are tired or stressed? The answer lies in the hypothalamus. Retatrutide doesn't just "fill up the stomach"—it actually recalibrates the feedback loops that define hunger.</p>
      
      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">The "Food Noise" Phenomenon</h2>
      <p class="mb-6 leading-relaxed">For many researchers, the most profound effect of Retatrutide is the silence. "Food Noise"—the constant, background mental chatter about the next meal—is effectively muted. This happens through the synergy of GIP and GLP-1 agonism, which slows the dopamine reward response to hyper-palatable foods.</p>
      
      <div class="my-10 bg-evo-orange/5 border border-white/10 rounded-3xl p-8 text-center">
        <h3 class="text-white font-display font-bold text-2xl mb-2 italic">NEUROLOGICAL REWIRING</h3>
        <p class="text-gray-400 text-sm font-light">By lowering the 'reward' value of food, Retatrutide allows subjects to maintain a caloric deficit without the psychological trauma of constant deprivation.</p>
      </div>

      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">The GIP/GLP-1 Axis</h2>
      <p class="mb-6 leading-relaxed">GLP-1 handles the peripheral signaling (slower digestion), while GIP handles the central signaling (appetite suppression). When you add GCG (glucagon) into the mix, you get a subject that is not only full but has the cognitive energy to ignore food triggers entirely.</p>
    `,
    date: "Feb 04, 2026",
    category: "Safety",
    readTime: "8 min",
    imageUrl: "https://images.pexels.com/photos/1153370/pexels-photo-1153370.jpeg?auto=compress&cs=tinysrgb&w=800",
    references: [
      { label: "CNS Neuroscience & Therapeutics - Incretin Brain Signaling", url: "https://onlinelibrary.wiley.com/" }
    ]
  },
  {
    id: 'liver-health-nash',
    title: "Retatrutide and Liver Health: Exploring the Benefits for NASH/NAFLD",
    excerpt: "Exploring the benefits for hepatic triglyceride reduction and liver fat loss.",
    content: `
      <p class="mb-6 leading-relaxed">While the world focuses on the aesthetic benefits of Retatrutide, the scientific community is looking at the liver. Fatty liver disease (MAFLD/NASH) affects millions, and Retatrutide may be the first true pharmacological solution.</p>
      
      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">The 80% Liver Fat Reduction</h2>
      <p class="mb-6 leading-relaxed">In Phase 2 trials, researchers used MRI imaging to track liver fat. The results were staggering: over 80% of participants on the 12mg dose achieved <strong>Normal Liver Fat Levels (<5.5%)</strong> by week 48. This is a level of metabolic reversal previously only seen in extreme bariatric surgery.</p>

      <div class="my-12 flex flex-col items-center">
        <div class="w-full max-w-sm bg-[#0a0a0a] border border-white/5 rounded-3xl p-8 relative shadow-2xl">
          <div class="flex items-center gap-4 mb-6">
            <div class="w-12 h-12 bg-evo-orange/10 rounded-full flex items-center justify-center">
              <span class="text-evo-orange font-display font-black italic">!</span>
            </div>
            <div>
              <p class="text-[10px] text-gray-500 font-black uppercase tracking-widest leading-none mb-1">Breakthrough Data</p>
              <p class="text-white font-display font-bold">HEPATIC CLEARANCE</p>
            </div>
          </div>
          <p class="text-[10px] text-gray-400 font-light leading-relaxed mb-6">Subjects with high baseline liver fat showed an average reduction of 81.4%—effectively reversing years of metabolic damage.</p>
        </div>
      </div>

      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">The Glucagon Liver Link</h2>
      <p class="mb-6 leading-relaxed">How does it work? Glucagon receptor agonism specifically targets the liver, signaling it to stop storing glycogen and start exporting lipids to be used for energy. Essentially, it "cleans" the liver from the inside out.</p>
    `,
    date: "Feb 03, 2026",
    category: "Safety",
    readTime: "7 min",
    imageUrl: "https://images.pexels.com/photos/4021775/pexels-photo-4021775.jpeg?auto=compress&cs=tinysrgb&w=800",
    references: [
      { label: "Hepatology Journal - Triple Agonist Liver Impact", url: "https://aasldpubs.onlinelibrary.wiley.com/" }
    ]
  },
  {
    id: 'buying-peptides-online',
    title: "Buying Peptides Online: 5 Red Flags to Watch For (And Why EVO is Different)",
    excerpt: "How to verify a domestic vendor and avoid common scams in the research space.",
    content: `
      <p class="mb-6 leading-relaxed">The online peptide marketplace is the "Wild West." For every legitimate vendor, there are ten "resellers" shipping untested, low-purity vials from overseas. Here is how to protect your research and your budget.</p>
      
      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">Red Flag Checklist</h2>
      <div class="space-y-4 mb-10">
        <div class="flex items-start gap-4 p-4 bg-white/5 rounded-xl border border-white/5">
          <span class="text-evo-orange font-black italic text-sm">01.</span>
          <div>
            <p class="text-white text-xs font-bold uppercase mb-1">No 3rd Party HPLC</p>
            <p class="text-gray-500 text-[10px] uppercase font-light leading-relaxed">If they only show "internal" reports or none at all, the batch is unverified.</p>
          </div>
        </div>
        <div class="flex items-start gap-4 p-4 bg-white/5 rounded-xl border border-white/5">
          <span class="text-evo-orange font-black italic text-sm">02.</span>
          <div>
            <p class="text-white text-xs font-bold uppercase mb-1">"Ships from Overseas"</p>
            <p class="text-gray-500 text-[10px] uppercase font-light leading-relaxed">Customs seizures and storage temperature risks make international shipping a gamble.</p>
          </div>
        </div>
        <div class="flex items-start gap-4 p-4 bg-white/5 rounded-xl border border-white/5">
          <span class="text-evo-orange font-black italic text-sm">03.</span>
          <div>
            <p class="text-white text-xs font-bold uppercase mb-1">Unrealistic Pricing</p>
            <p class="text-gray-500 text-[10px] uppercase font-light leading-relaxed">High-purity synthesis of Retatrutide is expensive. "Too good to be true" prices mean underdosed vials.</p>
          </div>
        </div>
      </div>

      <h2 class="text-2xl font-display font-bold text-white mb-6 uppercase italic tracking-tight">The Evo™ Difference</h2>
      <p class="mb-6 leading-relaxed">At Evo™ Peptides, we control the path from synthesis to your door. We specialize in <strong>Domestic Ready-Stock</strong> delivery within Malaysia, ensuring your cold-chain logistics are never compromised. When you buy from Evo, you are buying a verified clinical tool, supported by real-time lab data and expert support.</p>
      
      <div class="my-10 bg-gradient-to-br from-evo-orange to-evo-orange/50 p-10 rounded-[3rem] shadow-2xl text-center">
        <h3 class="text-black font-display font-black text-3xl uppercase italic leading-none mb-4">READY FOR RESEARCH?</h3>
        <p class="text-black/70 font-bold uppercase tracking-widest text-[10px] mb-6">Stop gambling with your research. Join the Evo vanguard.</p>
        <div class="inline-block px-8 py-3 bg-black text-white font-black text-xs uppercase tracking-[0.2em] rounded-full hover:scale-105 transition-transform">Browse Shop</div>
      </div>
    `,
    date: "Feb 02, 2026",
    category: "Safety",
    readTime: "5 min",
    imageUrl: "https://images.pexels.com/photos/221185/pexels-photo-221185.jpeg?auto=compress&cs=tinysrgb&w=800",
    references: [
      { label: "Federal Trade Commission - Peptide Fraud Trends", url: "https://www.ftc.gov/" }
    ]
  }
];
